Skip to main content

Silverarc Capital Management, LLC

13F filer · CIK 0001816307
Reported Aug 13, 2026
Net seller this quarter
13F portfolio value$962MU.S. long equity reported on 13F
Positions6519 new · 21 closed
Net flow last quarter-$91.9MBuys minus sells
Top 10 positions weight42.3%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 13, 202665 positions
ASNDAscendis Pharma A/S$55M5.72%0.33%+65.4%Q4 2020
CELCCelcuity Inc.$52.4M5.45%1.02%+40.0%Q3 2025
COGTCogent Biosciences, Inc.$49.6M5.15%0.75%-2.6%Q4 2020
URGNUroGen Pharma Ltd.$47.9M4.98%2.66%-13.4%Q3 2023
IMNMImmunome Inc.$42.7M4.44%1.78%+9.0%Q1 2024
DNTHDianthus Therapeutics, Inc.$38M3.95%0.71%-40.4%Q1 2025
RYTMRhythm Pharmaceuticals, Inc.$34.6M3.59%0.45%+1.8%Q2 2023
ORKAOruka Therapeutics, Inc.$33.6M3.49%0.58%+133.8%Q2 2025
GLUEMonte Rosa Therapeutics, Inc.$26.8M2.79%1.30%-44.6%Q1 2023
SNDXSyndax Pharmaceuticals Inc$26.5M2.76%1.36%+36.6%Q4 2020
ELVNEnliven Therapeutics, Inc.$24.8M2.58%0.67%Not reportedQ2 2025
IMVTImmunovant, Inc.$23.9M2.48%0.30%+49.5%Q4 2020
ERASErasca, Inc.$23.1M2.40%0.40%-31.8%Q3 2021
SGMTSagimet Biosciences Inc.$22.6M2.35%9.54%Not reportedQ3 2023
ABVXAbivax S.A.$22.6M2.35%0.22%-43.9%Q1 2024
PRAXPraxis Precision Medicines, Inc.$22M2.29%0.24%-8.2%Q3 2022
KODKodiak Sciences Inc.$21.3M2.21%0.87%-44.9%Q3 2023
DFTXDefinium Therapeutics, Inc.$18.8M1.96%0.30%NewQ2 2026
VCYTVeracyte, Inc.$18.7M1.94%0.40%+77.0%Q1 2021
GHGuardant Health, Inc.$15M1.56%0.07%+1.3%Q4 2020
CCCCC4 Therapeutics, Inc.$14.2M1.47%2.47%+58.6%Q1 2024
ZBIOZenas BioPharma, Inc.$12.9M1.34%0.81%-55.1%Q1 2026
TRVITrevi Therapeutics, Inc.$12.6M1.31%0.48%+32.7%Q3 2022
HLXCHelix Acquisition Corp. III$12.5M1.30%Not reported-2.6%Q1 2026
ALXOAlx Oncology Holdings Inc$11.9M1.24%4.16%NewQ2 2026
MANEVeradermics, Inc$11.7M1.21%0.23%NewQ2 2026
XENEXenon Pharmaceuticals Inc.$11.3M1.17%0.19%-5.5%Q3 2021
AVLNAvalyn Pharma Inc.$10.9M1.13%0.75%NewQ2 2026
BIIBBiogen Inc.$10.4M1.08%0.03%-5.6%Q4 2020
ACRSAclaris Therapeutics, Inc.$10.3M1.07%1.39%Not reportedQ1 2021
CERSCerus Corp$10.1M1.05%1.73%+9.3%Q2 2021
AVTXAvalo Therapeutics, Inc.$9.25M0.96%0.95%Not reportedQ3 2025
BNTCBenitec Biopharma Inc.$9.1M0.95%1.98%-5.3%Q2 2021
PCVXVaxcyte, Inc.$8.43M0.88%0.10%0.0%Q4 2022
WGSGeneDx Holdings Corp.$8.39M0.87%0.41%NewQ2 2026
SVRASavara Inc$8.35M0.87%0.66%-5.3%Q1 2026
OVIDOvid Therapeutics Inc.$8.34M0.87%1.68%+210.1%Q1 2026
ORICOric Pharmaceuticals, Inc.$8M0.83%0.71%-32.8%Q2 2022
CMPSCOMPASS Pathways plc$7.12M0.74%0.37%+67.8%Q1 2026
CGENCompugen Ltd$6.81M0.71%3.37%-4.0%Q4 2020
SLDBSolid Biosciences Inc.$6.68M0.69%0.64%Not reportedQ4 2023
IBIOiBio, Inc.$6.16M0.64%6.32%+1457.7%Q4 2025
IRONDisc Medicine, Inc.$6.06M0.63%0.22%-57.8%Q2 2024
ALKSAlkermes plc.$5.95M0.62%0.07%-75.3%Q2 2023
SYRESpyre Therapeutics, Inc.$5.32M0.55%0.07%-67.9%Q4 2025
ARTVArtiva Biotherapeutics, Inc.$5.09M0.53%2.12%NewQ2 2026
CTNMContineum Therapeutics, Inc.$4.85M0.50%1.28%-1.9%Q3 2025
QUREuniQure N.V.$4.84M0.50%0.15%Not reportedQ2 2021
RACCResearch Alliance Corp III$3.85M0.40%Not reportedNewQ2 2026
ABEOAbeona Therapeutics Inc.$3.77M0.39%1.07%-5.9%Q2 2025
Q1 2026Reported May 14, 202667 positions
KALVKalVista Pharmaceuticals, Inc.$57.9M5.91%5.61%+18.5%Q1 2021
DNTHDianthus Therapeutics, Inc.$54.9M5.61%1.20%-12.7%Q1 2025
COGTCogent Biosciences, Inc.$50.6M5.16%0.77%+5.5%Q4 2020
CELCCelcuity Inc.$40.9M4.17%0.74%-4.6%Q3 2025
IMNMImmunome Inc.$40.5M4.13%1.63%+64.3%Q1 2024
KODKodiak Sciences Inc.$37.8M3.86%1.60%-3.1%Q3 2023
NUVLNuvalent, Inc.$36.4M3.71%11.34%+14.0%Q3 2022
ABVXAbivax S.A.$33.7M3.44%0.39%-28.3%Q1 2024
GLUEMonte Rosa Therapeutics, Inc.$32.9M3.36%2.37%+94.6%Q1 2023
ERASErasca, Inc.$30M3.06%0.60%+40.6%Q3 2021
ASNDAscendis Pharma A/S$28.5M2.91%0.20%+153.2%Q4 2020
URGNUroGen Pharma Ltd.$27M2.76%3.09%-13.6%Q3 2023
RYTMRhythm Pharmaceuticals, Inc.$26.6M2.72%0.45%+125.1%Q2 2023
PRAXPraxis Precision Medicines, Inc.$23.1M2.35%0.26%-13.2%Q3 2022
ZBIOZenas BioPharma, Inc.$22.2M2.27%1.82%NewQ1 2026
SNDXSyndax Pharmaceuticals Inc$20.8M2.12%1.00%+38.3%Q4 2020
CNTACentessa Pharmaceuticals PLC$18.5M1.89%0.30%+1.8%Q3 2024
SRRKScholar Rock Holding Corp$16.7M1.70%0.29%Not reportedQ4 2020
ALKSAlkermes plc.$16.3M1.66%0.28%Not reportedQ2 2023
ORICOric Pharmaceuticals, Inc.$13.9M1.42%1.06%-1.5%Q2 2022
IRONDisc Medicine, Inc.$12.5M1.28%0.51%Not reportedQ2 2024
HLXCHelix Acquisition Corp. III$12.3M1.25%Not reportedNewQ1 2026
XENEXenon Pharmaceuticals Inc.$11.5M1.17%0.20%Not reportedQ3 2021
CGONCG Oncology, Inc.$11.3M1.15%0.19%-53.9%Q2 2025
IMVTImmunovant, Inc.$10.3M1.05%0.20%Not reportedQ4 2020
SYRESpyre Therapeutics, Inc.$9.41M0.96%0.24%-0.6%Q4 2025
BIIBBiogen Inc.$9.34M0.95%0.03%-32.4%Q4 2020
GHGuardant Health, Inc.$9.1M0.93%0.07%+7.2%Q4 2020
PCVXVaxcyte, Inc.$8.42M0.86%0.10%-2.6%Q4 2022
SVRASavara Inc$7.81M0.80%0.70%NewQ1 2026
BNTCBenitec Biopharma Inc.$7.64M0.78%2.09%-1.9%Q2 2021
ORKAOruka Therapeutics, Inc.$7.4M0.76%0.30%Not reportedQ2 2025
CGENCompugen Ltd$7.06M0.72%3.51%-4.7%Q4 2020
TRVITrevi Therapeutics, Inc.$6.1M0.62%0.40%-5.6%Q3 2022
INSMINSMED Inc$5.86M0.60%0.02%-49.7%Q4 2020
VCYTVeracyte, Inc.$5.79M0.59%0.23%-49.7%Q1 2021
CERSCerus Corp$5.78M0.59%1.65%+12.9%Q2 2021
CLDXCelldex Therapeutics, Inc.$5.66M0.58%0.27%-6.6%Q4 2020
CCCCC4 Therapeutics, Inc.$5.03M0.51%1.84%-4.1%Q1 2024
CYTKCytokinetics Inc$4.69M0.48%0.06%Not reportedQ3 2021
CLYMClimb Bio, Inc.$4.69M0.48%1.43%Not reportedQ1 2022
CMPXCompass Therapeutics, Inc.$4.54M0.46%0.48%-18.3%Q3 2022
SRZNSurrozen, Inc.$4.2M0.43%1.26%-8.3%Q4 2025
CTNMContineum Therapeutics, Inc.$3.94M0.40%1.31%-1.9%Q3 2025
ZURAZura Bio Ltd$3.34M0.34%0.59%Not reportedQ2 2023
FULCFulcrum Therapeutics, Inc.$3.22M0.33%0.63%+6.4%Q4 2020
ABEOAbeona Therapeutics Inc.$2.91M0.30%1.14%+3.4%Q2 2025
CAMPCamp4 Therapeutics Corp$2.88M0.29%1.26%Not reportedQ3 2025
ANNXAnnexon, Inc.$2.75M0.28%0.33%Not reportedQ2 2023
ELUTElutia Inc.$2.62M0.27%385.09%-9.2%Q1 2024
Q4 2025Reported Feb 12, 202664 positions
ABVXAbivax S.A.$56.9M7.91%0.54%-21.8%Q1 2024
COGTCogent Biosciences, Inc.$44.2M6.14%0.77%+52.8%Q4 2020
URGNUroGen Pharma Ltd.$40.7M5.66%3.60%+10.2%Q3 2023
KALVKalVista Pharmaceuticals, Inc.$39.2M5.44%4.77%+78.0%Q1 2021
CELCCelcuity Inc.$37.4M5.20%0.78%+323.0%Q3 2025
NUVLNuvalent, Inc.$31.3M4.35%9.95%-16.4%Q3 2022
DNTHDianthus Therapeutics, Inc.$30.9M4.29%1.74%+11.1%Q1 2025
KODKodiak Sciences Inc.$28.6M3.97%1.66%+2.3%Q3 2023
PRAXPraxis Precision Medicines, Inc.$24.3M3.38%0.33%+61.0%Q3 2022
IMNMImmunome Inc.$24.2M3.36%1.00%Not reportedQ1 2024
GUTSFractyl Health, Inc.$21.6M3.01%6.42%-7.2%Q1 2024
GLUEMonte Rosa Therapeutics, Inc.$16.1M2.24%1.57%+48.1%Q1 2023
VCYTVeracyte, Inc.$15.1M2.09%0.45%+51.6%Q1 2021
CGONCG Oncology, Inc.$15M2.08%0.45%-43.4%Q2 2025
RYTMRhythm Pharmaceuticals, Inc.$14.6M2.02%0.20%-63.3%Q2 2023
SNDXSyndax Pharmaceuticals Inc$13.5M1.88%0.74%+38.6%Q4 2020
BIIBBiogen Inc.$13.3M1.84%0.05%-6.2%Q4 2020
INSMINSMED Inc$12.4M1.72%0.03%-65.5%Q4 2020
CNTACentessa Pharmaceuticals PLC$11.5M1.59%0.31%+224.4%Q3 2024
VRDNViridian Therapeutics, Inc.\DE$10.8M1.51%0.34%+34.3%Q1 2021
ASNDAscendis Pharma A/S$10.5M1.46%0.08%-8.1%Q4 2020
PFEPfizer Inc$10.4M1.45%0.01%Not reportedQ2 2025
BNTCBenitec Biopharma Inc.$9.86M1.37%2.14%+164.9%Q2 2021
AVTXAvalo Therapeutics, Inc.$9.52M1.32%2.83%-27.3%Q3 2025
GHGuardant Health, Inc.$9.39M1.30%0.07%Not reportedQ4 2020
ORICOric Pharmaceuticals, Inc.$9.13M1.27%1.13%-42.7%Q2 2022
PCVXVaxcyte, Inc.$6.87M0.95%0.11%-52.7%Q4 2022
TRVITrevi Therapeutics, Inc.$6.78M0.94%0.42%-8.1%Q3 2022
GOSSGossamer Bio, Inc.$6.62M0.92%0.91%-55.3%Q4 2022
SYRESpyre Therapeutics, Inc.$6.15M0.85%0.24%NewQ4 2025
LXEOLexeo Therapeutics, Inc.$6.13M0.85%0.85%-20.7%Q3 2025
AMLXAmylyx Pharmaceuticals, Inc.$6.12M0.85%0.46%-27.7%Q1 2022
CERSCerus Corp$5.8M0.81%1.46%+3.6%Q2 2021
CMPXCompass Therapeutics, Inc.$5.65M0.78%0.59%-62.9%Q3 2022
SLNOSoleno Therapeutics Inc$5.44M0.76%0.22%Not reportedQ4 2020
CGENCompugen Ltd$5.32M0.74%3.68%+5.1%Q4 2020
CLDXCelldex Therapeutics, Inc.$5.19M0.72%0.29%-45.2%Q4 2020
OLMAOlema Pharmaceuticals, Inc.$5.16M0.72%0.25%-77.9%Q2 2023
ERASErasca, Inc.$4.9M0.68%0.46%-3.7%Q3 2021
FULCFulcrum Therapeutics, Inc.$4.46M0.62%0.59%Not reportedQ4 2020
AARDAardvark Therapeutics, Inc.$3.99M0.55%1.39%-1.0%Q1 2025
CCCCC4 Therapeutics, Inc.$3.81M0.53%2.06%+5.1%Q1 2024
SRZNSurrozen, Inc.$3.56M0.49%1.61%NewQ4 2025
CTNMContineum Therapeutics, Inc.$3.52M0.49%1.33%+85.1%Q3 2025
MLYSMineralys Therapeutics, Inc.$3.45M0.48%0.12%+18.7%Q1 2024
RLAYRelay Therapeutics, Inc.$3.37M0.47%0.23%Not reportedQ3 2024
ABEOAbeona Therapeutics Inc.$3.31M0.46%1.14%-36.9%Q2 2025
TELATELA Bio, Inc.$3.12M0.43%5.94%-4.9%Q1 2023
QUREuniQure N.V.$3.02M0.42%0.20%-72.3%Q2 2021
TARSTarsus Pharmaceuticals, Inc.$2.96M0.41%0.08%Not reportedQ2 2024
Q3 2025Reported Nov 12, 202573 positions
ABVXAbivax S.A.$45.8M6.18%0.85%Not reportedQ1 2024
RYTMRhythm Pharmaceuticals, Inc.$37.4M5.04%0.55%-7.7%Q2 2023
RNAMAvidity Biosciences, Inc.$36.8M4.96%0.58%+106.0%Q4 2022
NUVLNuvalent, Inc.$32.2M4.34%11.90%+58.0%Q3 2022
URGNUroGen Pharma Ltd.$31.5M4.24%3.37%-22.0%Q3 2023
AKROAkero Therapeutics, Inc.$30.6M4.12%0.80%-9.8%Q4 2020
INSMINSMED Inc$29.8M4.01%0.10%-17.0%Q4 2020
DNTHDianthus Therapeutics, Inc.$26.6M3.58%1.58%+604.5%Q1 2025
QUREuniQure N.V.$26.6M3.58%0.73%+124.6%Q2 2021
CGONCG Oncology, Inc.$25.7M3.47%0.82%+18.0%Q2 2025
ORICOric Pharmaceuticals, Inc.$23.4M3.15%2.00%+8.2%Q2 2022
CDTXCidara Therapeutics, Inc.$21.2M2.85%0.75%+112.5%Q2 2025
GUTSFractyl Health, Inc.$16.9M2.27%8.02%+5132.2%Q1 2024
KALVKalVista Pharmaceuticals, Inc.$16.6M2.24%2.70%-25.6%Q1 2021
KODKodiak Sciences Inc.$16.4M2.21%1.89%+149.0%Q3 2023
GOSSGossamer Bio, Inc.$12.6M1.69%2.07%-7.1%Q4 2022
COGTCogent Biosciences, Inc.$11.7M1.58%0.58%Not reportedQ4 2020
CYTKCytokinetics Inc$11.6M1.56%0.18%Not reportedQ3 2021
PCVXVaxcyte, Inc.$11.3M1.53%0.24%+9.2%Q4 2022
BIIBBiogen Inc.$11.3M1.52%0.05%Not reportedQ4 2020
ASNDAscendis Pharma A/S$10.6M1.44%0.09%-38.1%Q4 2020
CMPXCompass Therapeutics, Inc.$9.92M1.34%1.60%+126.8%Q3 2022
AMLXAmylyx Pharmaceuticals, Inc.$9.51M1.28%0.64%Not reportedQ1 2022
VSTMVerastem, Inc.$9.21M1.24%1.56%Not reportedQ4 2020
AVTXAvalo Therapeutics, Inc.$9.16M1.24%4.04%NewQ3 2025
OLMAOlema Pharmaceuticals, Inc.$9.14M1.23%1.36%Not reportedQ2 2023
CLDXCelldex Therapeutics, Inc.$9.03M1.22%0.53%+75.8%Q4 2020
SRRKScholar Rock Holding Corp$8.71M1.17%0.24%-31.4%Q4 2020
VCYTVeracyte, Inc.$8.09M1.09%0.30%-47.4%Q1 2021
SNDXSyndax Pharmaceuticals Inc$7.13M0.96%0.53%+15.1%Q4 2020
RAPPRapport Therapeutics, Inc.$6.06M0.82%0.43%NewQ3 2025
VRDNViridian Therapeutics, Inc.\DE$5.6M0.76%0.32%Not reportedQ1 2021
ALKSAlkermes plc.$5.42M0.73%0.11%Not reportedQ2 2023
TRVITrevi Therapeutics, Inc.$5.39M0.73%0.46%+9.1%Q3 2022
BBOTBridgeBio Oncology Therapeutics, Inc.$5.3M0.71%0.58%-25.4%Q1 2024
ABEOAbeona Therapeutics Inc.$5.25M0.71%1.90%+8.4%Q2 2025
LXEOLexeo Therapeutics, Inc.$5.17M0.70%1.42%NewQ3 2025
GLUEMonte Rosa Therapeutics, Inc.$5.15M0.69%1.12%Not reportedQ1 2023
CGENCompugen Ltd$4.87M0.66%3.54%+9.1%Q4 2020
PHVSPharvaris N.V.$4.59M0.62%0.34%Not reportedQ4 2022
CELCCelcuity Inc.$4.38M0.59%0.20%NewQ3 2025
CERSCerus Corp$4.32M0.58%1.42%+9.1%Q2 2021
CCCCC4 Therapeutics, Inc.$4.21M0.57%2.56%Not reportedQ1 2024
TELATELA Bio, Inc.$4.15M0.56%6.90%+0.1%Q1 2023
AARDAardvark Therapeutics, Inc.$4.08M0.55%1.41%+7.0%Q1 2025
BCAXBicara Therapeutics Inc.$3.96M0.53%0.46%NewQ3 2025
BNTCBenitec Biopharma Inc.$3.88M0.52%1.05%+9.1%Q2 2021
KNSAKiniksa Pharmaceuticals International, plc$3.45M0.47%Not reported+17.1%Q1 2025
CNTACentessa Pharmaceuticals PLC$3.43M0.46%0.11%+2724.8%Q3 2024
EYPTEyePoint, Inc.$3.29M0.44%0.33%Not reportedQ1 2021
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.